Pharmafile Logo
Pharmafocus logo
Advanced Search

Abbott

Showing 15 posts of 102 posts found.

Abbvie image

AbbVie ‘pleased’ with first year

February 3, 2014
Sales and Marketing AbbVie, Abbott, CLL, EMA, HIV, Humira

Rheumatoid arthritis treatment Humira – as expected – has driven AbbVie in its first year as a standalone company, accounting …

News

Former Abbott head now director for UDG Healthcare

December 19, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, udg healthcare

Healthcare services provider UDG Healthcare has appointed Brendan McAtamney to be its executive director and announces two other senior hires. …

Appointment
dr_robert_brooks_web

Robert Brooks joins Achilles from Abbott

September 10, 2013
Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, Abbott, achilles, brook

Supply chain firm Achilles has hired Dr Robert Brooks to be a Business Development director from pharma firm Abbott. Brooks …

Appointment

Marginal sales increase for Abbott

July 18, 2013
Sales and Marketing AbbVie, Abbott, Q2

Abbott’s second quarter results saw the company buffeted by currency exchange issues – primarily the yen weakening against the US …

News
united_drug

United Drug hires Abbott VP

June 19, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Abbott, United Drug

Healthcare services firm United Drug has appointed Brendan McAtamney as chief operating officer with effect from September. McAtamney will be …

Appointment
Orencia image

Orencia matches Humira

June 13, 2013
Sales and Marketing AbbVie, Abbott, Humira, Orencia, RA

Bristol-Myers Squibb is hoping its biologic Orencia can grab a little more of the rheumatoid arthritis market after demonstrating non-inferiority …

News
Abbvie image

Sales rise for AbbVie

April 30, 2013
Sales and Marketing AbbVie, Abbott

AbbVie has released its first financial results as a standalone company since separating from Abbott as an $18 billion biopharma …

News
Humira image

AbbVie guards Humira data

March 13, 2013
Sales and Marketing AbbVie, Abbott, Humira, RA, transparency

AbbVie has issued two injunctions against the European Medicines Agency to prevent the regulator revealing data about rheumatoid arthritis drug …

News
Abbott image

Abbott seeks leukemia test

February 25, 2013
Sales and Marketing AbbVie, Abbott, Janssen

Abbott is to team up with Janssen Biotech and biopharma firm Pharmacyclics to seek a diagnostic test for leukemia patients. …

News

Sanofi won’t follow trend for spin-offs

February 8, 2013
Sales and Marketing Abbott, Pfizer, Sanofi, Viehbacher

Sanofi’s chief executive Chris Viehbacher says the firm plans to maintain its portfolio of business divisions for the foreseeable future, …

News

Abbott finishes strongly before spin-off

January 25, 2013
Sales and Marketing AbbVie, Abbott, Q4 2012

Abbott has presented its full-year results for 2012 – the last in which many of its products will appear, following …

News

AbbVie splits from Abbott

January 7, 2013
Sales and Marketing AbbVie, Abbott, HIV, Humira

AbbVie, the new $18 billion biopharma company which includes many of Abbott’s most high profile products, has finally launched. Abbott …

News
Humira image

Another indication for Humira

November 28, 2012
Sales and Marketing Abbott, Crohn's, EU, Humira

Abbott’s Humira has received its ninth indication in Europe with approval to treat youngsters suffering from the inflammatory bowel disease …

News

Abbott pulls kidney disease trial

October 22, 2012
Research and Development, Sales and Marketing Abbott, Reata, kidney

Abbott has terminated its Phase III trial of bardoxolone methyl in patients with kidney disease and diabetes after concerns over …

News
Humira image

Humira continues to drive Abbott

October 22, 2012
Sales and Marketing AbVie, Abbott, Humira, RA

Abbott Laboratories’ rheumatoid arthritis drug Humira has once again shown its value to the company with a strong performance in …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026